These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 8061020

  • 1. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
    Wagner FM, Reichenspurner H, Uberfuhr P, Kur F, Kaulbach HG, Meiser BM, Ziegler U, Reichart B.
    J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
    [Abstract] [Full Text] [Related]

  • 2. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M, Latter DA, Loertscher R.
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation.
    Shennib H, Massard G, Reynaud M, Noirclerc M.
    J Heart Lung Transplant; 1994 Aug; 13(3):514-9. PubMed ID: 8061029
    [Abstract] [Full Text] [Related]

  • 4. Acute rejection: significance of elapsed time after transplantation.
    Rizeq MN, Masek MA, Billingham ME.
    J Heart Lung Transplant; 1994 Aug; 13(5):862-8. PubMed ID: 7803428
    [Abstract] [Full Text] [Related]

  • 5. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DK.
    Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK, Bourge RC, White-Williams C, Naftel DC, Thomas FT, Thomas JM, Phillips MG.
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [Abstract] [Full Text] [Related]

  • 7. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
    Sevmis S, Emiroglu R, Karakayali F, Yagmurdur MC, Dalgic A, Moray G, Haberal M.
    Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
    Meiser BM, Uberfuhr P, Fuchs A, Schulze C, Nollert G, Mair H, Martin S, Pfeiffer M, Reichenspurner H, Kreuzer E, Reichart B.
    J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
    [Abstract] [Full Text] [Related]

  • 9. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
    Cherqui D, Duvoux C, Charlotte F, Humeres R, Lauzet JY, Métreau JM, Salvat A, Rotman N, Julien M, Fagniez PL.
    Gastroenterol Clin Biol; 1994 Aug; 18(2):115-22. PubMed ID: 8013792
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic cytolytic therapy in heart transplantation: monoclonal versus polyclonal antibody therapy.
    Laske A, Gallino A, Schneider J, Bauer EP, Carrel T, Pasic M, von Segesser LK, Turina MI.
    J Heart Lung Transplant; 1992 Aug; 11(3 Pt 1):557-63. PubMed ID: 1610864
    [Abstract] [Full Text] [Related]

  • 11. Reevaluation of steroid tapering after steroid pulse therapy for heart rejection.
    Lonquist JL, Radovancevic B, Vega JD, Burnett CM, Birovljev S, Saade NG, Duncan JM, Frazier OH.
    J Heart Lung Transplant; 1992 Aug; 11(5):913-9. PubMed ID: 1420239
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ, Gullestad L, Pak J, Slauson S, Valantine HA, Hunt SA.
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [Abstract] [Full Text] [Related]

  • 13. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 14. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate pulse therapy in the treatment of recurrent acute heart rejection.
    Bourge RC, Kirklin JK, White-Williams C, Naftel DC, George JF, Morrow R, Tarkka M, Welborn JM.
    J Heart Lung Transplant; 1992 Oct; 11(6):1116-24. PubMed ID: 1457434
    [Abstract] [Full Text] [Related]

  • 16. Induction with OKT3 and prostaglandin E1 in liver transplantation.
    Fisher RA, Posner M, Shiffman ML, Wolfe L, Lee HM.
    Transplant Sci; 1994 Dec; 4 Suppl 1():S1-8. PubMed ID: 7627450
    [Abstract] [Full Text] [Related]

  • 17. Induction therapy with OKT3 in pediatric liver-transplant recipients.
    Ryckman FC, Schroeder TJ, Pedersen SH, Dittrich VS, Balistreri WF.
    Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
    [Abstract] [Full Text] [Related]

  • 18. Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
    Chan GL, Weinstein SS, Vijayanagar RR.
    Clin Transplant; 1995 Apr; 9(2):106-14. PubMed ID: 7599398
    [Abstract] [Full Text] [Related]

  • 19. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts.
    Menkis AH, Powell AM, Novick RJ, McKenzie FN, Kostuk WJ, Pflugfelder PW, Brown JE, Rochon J, Chow LH, Stiller C.
    J Heart Lung Transplant; 1992 Apr; 11(3 Pt 1):569-76. PubMed ID: 1610866
    [Abstract] [Full Text] [Related]

  • 20. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson M, Heroux A, Kao W, Mullen GM, Radvany R, Robinson J.
    J Heart Lung Transplant; 1993 Apr; 12(5):779-89. PubMed ID: 8241215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.